COVAXIN’s animal trial gets robust immune responses: Bharat Biotech
Bharat Biotech International Limited has announced that its Covid-19 vaccine candidate, COVAXIN, has shown positive efficacy in animal studies and generated robust immune responses.COVAXIN, developed by the Indian Council of Medical…